Aplastic Anemia Treatment

The choice depends primarily on age, disease severity, and donor availability. For patients under 40 with severe or very severe aplastic anemia who have a matched sibling donor, bone marrow transplant is the preferred curative option with long-term success rates above 85%. For older patients, those without a matched donor, or those with non-severe disease, immunosuppressive therapy with horse-ATG or rabbit-ATG plus cyclosporine is the standard first-line approach, achieving responses in 60–70% of patients. Our partner hematologists will review your CBC, bone marrow biopsy, and HLA typing to provide a tailored recommendation before you travel.